Google
Trusted Resources: News & Events
Latest announcements and gatherings
Regina Hartfield Is Now the CEO and President of SCDAA
The Sickle Cell Disease Association of America (SCDAA) has a new president and CEO. After serving on the association’s board of directors for 3 years, and as the chair of the fundraising committee, Regina Hartfield assumed the position on January 14, 2022.
In an interview with HCPLive®, Hartfield shared her priorities for 2022 as the new leader of the association. One of the first priorities is to increase the amount of member organizations in partnership with SCDAA across the US. Currently, SCDAA partners with 53 organizations that span 29 states, collectively serving over 500,000 individuals with sickle cell disease (SCD).
Another pritority that Hartfield was excited to share was a clinical trial finder that SCDAA first launched in October 2021. The goal is to continue to grow number of people who have access to it and in turn, increase the amount of people participating in clinical trials.
+myBinderRelated Content
-
Lab-Grown Blood: What Is It, and How Could It Be Useful?Sometimes a person may have a blood diso...
-
Barbara Yawn, MDBarbara P. Yawn, MD, MSc, FAAFP, is Adju...
-
Patient controlled analgesia for adults with sickle cell disease awaiting admission from the emergency departmentBackground: A treatment algorithm for s...
-
The Vaso-Occlusive Pain Crisis in Sickle Cell Disease: Definition, Pathophysiology, and ManagementEarly diagnosis, treatment, and preventi...
-
Brigham and Women’s Sickle Cell Disease ClinicEach person with sickle cell disease is ...
-
John F. Tisdale, MDJohn F. Tisdale, MD graduated from the C...
-
Patient Perspective: Childhood Experiences of Sickle Cellhttps://www.youtube.com/watch?v=982zM-s4...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.